Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer


ABSTRACT: The neuroendocrine (NE) phenotype is associated with the development of metastatic castration-resistant prostate cancer (CRPC). Our objective was to characterize the molecular features of the NE phenotype in CRPC. Expression of chromogranin A (CHGA), synaptophysin (SYP), androgen receptor (AR), and prostate-specific antigen (PSA) was analyzed by immunohistochemistry (IHC) in 155 CRPC metastases from 50 patients and in 24 LuCaP prostate cancer patient-derived xenografts (PDX). Co-expression of CHGA and SYP in >30% of cells was observed in 22 of 155 metastases (9 patients); 11 of the 22 metastases were AR+/PSA+ (6 patients), 11/22 were AR-/PSA- (4 patients), and 4/24 LuCaP PDXs were AR-/PSA-. Seventy-one of 155 metastases and the 24 LuCaP xenograft lines were analyzed by whole genome microarrays. By IHC, of the 71 metastases analyzed by whole genome microarrays, 5 metastases were CHGA+/SYP+/AR- and 5 were CHGA+/SYP+/AR+. Only CHGA+/SYP+ metastases had a NE transcript signature. The neuronal transcriptional regulator SRRM4 transcript was associated with the NE signature in CHGA+/SYP+ metastases and all CHGA+/SYP+ LuCaP xenografts. Additionally, expression of SRRM4 in the LuCaP NE xenografts correlated with a splice variant of REST that lacks the transcriptional repressor domain. In conclusion, (a) metastatic NE status can be heterogeneous in the same patient, (b) the CRPC NE molecular phenotype can be defined by CHGA+/SYP+ dual positivity, (c) the NE phenotype is not necessarily associated with the loss of AR activity, and (d) the splicing of REST by SRRM4 could promote the NE phenotype in CRPC. Custom Agilent 44K whole human genome expression oligonucleotide microarrays were used to profile 24 LuCaP PCa xenograft lines and 71 CRPC metastases from 47 patients. RNA was amplified prior to hybridization against a common reference pool of prostate tumor cell lines.

ORGANISM(S): Homo sapiens

SUBMITTER: Ilsa Coleman 

PROVIDER: E-GEOD-66187 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer.

Zhang Xiaotun X   Coleman Ilsa M IM   Brown Lisha G LG   True Lawrence D LD   Kollath Lori L   Lucas Jared M JM   Lam Hung-Ming HM   Dumpit Ruth R   Corey Eva E   Chéry Lisly L   Lakely Bryce B   Higano Celestia S CS   Montgomery Bruce B   Roudier Martine M   Lange Paul H PH   Nelson Peter S PS   Vessella Robert L RL   Morrissey Colm C  

Clinical cancer research : an official journal of the American Association for Cancer Research 20150612 20


<h4>Purpose</h4>The neuroendocrine phenotype is associated with the development of metastatic castration-resistant prostate cancer (CRPC). Our objective was to characterize the molecular features of the neuroendocrine phenotype in CRPC.<h4>Experimental design</h4>Expression of chromogranin A (CHGA), synaptophysin (SYP), androgen receptor (AR), and prostate-specific antigen (PSA) was analyzed by IHC in 155 CRPC metastases from 50 patients and in 24 LuCaP prostate cancer patient-derived xenografts  ...[more]

Similar Datasets

2015-06-24 | GSE66187 | GEO
2016-02-16 | E-GEOD-77930 | biostudies-arrayexpress
2015-12-18 | E-GEOD-74685 | biostudies-arrayexpress
2016-02-12 | E-GEOD-55030 | biostudies-arrayexpress
2016-02-12 | E-GEOD-55031 | biostudies-arrayexpress
2016-02-12 | GSE71704 | GEO
2016-02-12 | E-GEOD-71704 | biostudies-arrayexpress
2014-09-11 | E-GEOD-61303 | biostudies-arrayexpress
2016-02-12 | GSE55031 | GEO
2016-02-12 | GSE55030 | GEO